Diane J Nugent

Summary

Affiliation: Children's Hospital of Orange County
Country: USA

Publications

  1. ncbi request reprint Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro
    Mei Chang
    Hemostasis and Thrombosis, Children s Hospital of Orange County, 455 S Main St, Orange, CA 92868, USA
    Blood 102:887-95. 2003
  2. ncbi request reprint Prophylaxis in rare coagulation disorders -- factor XIII deficiency
    Diane J Nugent
    Division of Hematology, Hemostasis Thrombosis Research, Children s Hospital of Orange County, Orange, CA 92868, USA
    Thromb Res 118:S23-8. 2006
  3. doi request reprint Factor XIII deficiency
    L Hsieh
    Division of Hematology, Children s Hospital of Orange County, Orange, CA 92868, USA
    Haemophilia 14:1190-200. 2008
  4. ncbi request reprint Recombinant activated factor VII effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, argatroban, and bivalirudin ex vivo as measured using thromboelastography
    Guy Young
    Department of Hematology, Children s Hospital of Orange County, Orange, California, USA
    Blood Coagul Fibrinolysis 18:547-53. 2007
  5. ncbi request reprint Differential effects of direct thrombin inhibitors and antithrombin-dependent anticoagulants on the dynamics of clot formation
    Guy Young
    Department of Hematology, Children s Hospital of Orange County, Orange, California 92868, USA
    Blood Coagul Fibrinolysis 18:97-103. 2007
  6. doi request reprint Off-label use of rFVIIa in children with excessive bleeding: a consecutive study of 153 off-label uses in 139 children
    Guy Young
    Children s Hospital of Orange County, Orange, California, USA
    Pediatr Blood Cancer 53:179-83. 2009
  7. ncbi request reprint Identification of a novel regulatory element in the human interleukin 1 alpha (IL-1alpha) gene promoter
    Frank Zaldivar
    Immune and Inflammatory Disease Research, Children s Hospital of Orange County CHOC Research Institute, Orange, CA 92868, USA
    Cytokine 20:130-5. 2002
  8. ncbi request reprint Argatroban as an alternative to heparin in extracorporeal membrane oxygenation circuits
    Guy Young
    Division of Hematology, Children s Hospital of Orange County, Orange, CA 92868, USA
    Perfusion 19:283-8. 2004
  9. ncbi request reprint Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency
    Amy E Lovejoy
    Department of Hematology, Children s Hospital of Orange County, Orange, CA 92868, USA
    Blood 108:57-62. 2006
  10. doi request reprint Genetic variants that affect platelet function
    Thomas J Kunicki
    Hematology Research, CHOC Children s Hospital, University of California, Irvine, Orange, USA
    Curr Opin Hematol 19:371-9. 2012

Collaborators

Detail Information

Publications16

  1. ncbi request reprint Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro
    Mei Chang
    Hemostasis and Thrombosis, Children s Hospital of Orange County, 455 S Main St, Orange, CA 92868, USA
    Blood 102:887-95. 2003
    ..Taken together, these data indicate that autoantibodies against either platelet GPIb or platelet GPIIb/IIIa in ITP plasma not only are involved in platelet destruction, but may also contribute to the inhibition of platelet production...
  2. ncbi request reprint Prophylaxis in rare coagulation disorders -- factor XIII deficiency
    Diane J Nugent
    Division of Hematology, Hemostasis Thrombosis Research, Children s Hospital of Orange County, Orange, CA 92868, USA
    Thromb Res 118:S23-8. 2006
    ..The development of registries such as that in the USA will enable the different manifestations of the disease to be explored...
  3. doi request reprint Factor XIII deficiency
    L Hsieh
    Division of Hematology, Children s Hospital of Orange County, Orange, CA 92868, USA
    Haemophilia 14:1190-200. 2008
    ..Although there is a lifelong risk of bleeding, the prognosis is excellent when current prophylactic treatment is available using cryoprecipitate or plasma-derived FXIII concentrate...
  4. ncbi request reprint Recombinant activated factor VII effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, argatroban, and bivalirudin ex vivo as measured using thromboelastography
    Guy Young
    Department of Hematology, Children s Hospital of Orange County, Orange, California, USA
    Blood Coagul Fibrinolysis 18:547-53. 2007
    ..In conclusion, rFVIIa effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, argatroban, and bivalirudin, and should be considered for patients with excessive bleeding associated with these anticoagulants...
  5. ncbi request reprint Differential effects of direct thrombin inhibitors and antithrombin-dependent anticoagulants on the dynamics of clot formation
    Guy Young
    Department of Hematology, Children s Hospital of Orange County, Orange, California 92868, USA
    Blood Coagul Fibrinolysis 18:97-103. 2007
    ..The reduced bleeding reported with DTIs versus heparin may relate to the fact that clots form with normal rigidity and elasticity...
  6. doi request reprint Off-label use of rFVIIa in children with excessive bleeding: a consecutive study of 153 off-label uses in 139 children
    Guy Young
    Children s Hospital of Orange County, Orange, California, USA
    Pediatr Blood Cancer 53:179-83. 2009
    ..Recombinant factor VIIa is a general hemostatic agent. Randomized trials have demonstrated effectiveness in adults; however, data in children are confined to case reports and series subject to publication bias...
  7. ncbi request reprint Identification of a novel regulatory element in the human interleukin 1 alpha (IL-1alpha) gene promoter
    Frank Zaldivar
    Immune and Inflammatory Disease Research, Children s Hospital of Orange County CHOC Research Institute, Orange, CA 92868, USA
    Cytokine 20:130-5. 2002
    ..These results will contribute to understanding of the regulatory mechanisms governing induction of the IL-1alpha gene and may lead to the isolation of a novel transcription factor...
  8. ncbi request reprint Argatroban as an alternative to heparin in extracorporeal membrane oxygenation circuits
    Guy Young
    Division of Hematology, Children s Hospital of Orange County, Orange, CA 92868, USA
    Perfusion 19:283-8. 2004
    ..These results suggest that argatroban may be more efficacious than heparin for anticoagulation in ECMO. Additional studies are warranted to further evaluate argatroban in this setting...
  9. ncbi request reprint Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency
    Amy E Lovejoy
    Department of Hematology, Children s Hospital of Orange County, Orange, CA 92868, USA
    Blood 108:57-62. 2006
    ..Recombinant FXIII appears to be a safe and potentially effective alternative for FXIII replacement in patients with FXIII deficiency...
  10. doi request reprint Genetic variants that affect platelet function
    Thomas J Kunicki
    Hematology Research, CHOC Children s Hospital, University of California, Irvine, Orange, USA
    Curr Opin Hematol 19:371-9. 2012
    ....
  11. ncbi request reprint Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children
    Michael D Tarantino
    Comprehensive Bleeding Disorders Center, University of Illinois College of Medicine, Peoria, Illinois 61614, and Children s Hospital of Orange County, Orange, California, USA
    J Pediatr 148:489-94. 2006
    ....
  12. pmc Thrombopoietin initiates demethylation-based transcription of GP6 during megakaryocyte differentiation
    Sachiko Kanaji
    Roon Research Center for Arteriosclerosis and Thrombosis, Division of Experimental Hemostasis and Thrombosis, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA
    Blood 105:3888-92. 2005
    ..In every case, demethylation of the GP6 promoter correlated with an increase in mRNA level. Thus, megakaryocyte-specific expression of the GP6 gene is regulated, in part, by CpG demethylation, which can be directly initiated by TPO...
  13. pmc Transcriptional and epigenetic regulation of the integrin collagen receptor locus ITGA1-PELO-ITGA2
    Yann Cheli
    The Roon Research Center for Arteriosclerosis and Thrombosis, Division of Experimental Hemostasis and Thrombosis, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA
    Biochim Biophys Acta 1769:546-58. 2007
    ..Thus, selective CpG methylation of the ITGA1 promoter is a specific feature of alpha1beta1 regulation that coincides with the initiation of megakaryocyte differentiation...
  14. ncbi request reprint Sustained engraftment post bone marrow transplant despite anti-platelet antibodies in Glanzmann thrombasthenia
    Veronica H Flood
    Pediatric Stem Cell Transplant Program, Division of Pediatric Hematology Oncology, Oregon Health and Science University, Portland, Oregon 97239, USA
    Pediatr Blood Cancer 45:971-5. 2005
    ..We report three patients who received bone marrow transplantation (BMT) for type I GT and discuss the risk and management of anti-platelet antibodies...
  15. ncbi request reprint The influence of platelet glycoprotein polymorphisms on receptor function and risk for thrombosis
    Thomas J Kunicki
    The Scripps Research Institute, La Jolla, CA, USA
    Vox Sang 83:85-90. 2002
    ..The opportunity now exists to make significant inroads into the development of strategies for the prevention of thrombotic disease...
  16. ncbi request reprint Influence of platelet collagen receptor polymorphisms on risk for arterial thrombosis
    Kenichi Furihata
    Roon Research Center for Arteriosclerosis and Thrombosis, Division of Experimental Hemostasis and Thrombosis, Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA
    Arch Pathol Lab Med 126:305-9. 2002
    ..More recently, we found that there is roughly a fivefold range in platelet glycoprotein VI content among normal individuals, which may also influence risk for thromboembolism...